Skip to main content
Premium Trial:

Request an Annual Quote

New Products: LifeCodexx's PraenaTest

Premium

LifeCodexx is now offering three options for its next-gen sequencing-based noninvasive fetal aneuploidy test, PraenaTest. The standard option includes testing for trisomies 21, 18, and 13. One option includes testing for only trisomy 21. An expanded option includes testing for trisomies 21, 18, and 13, as well as the determination of fetal gonosomal aneuploidy for singleton pregnancies, such as Turner, Triple X, Klinefelter, and XYY syndromes. In addition, starting in 2015, patients will be able to be refunded by their statutory health insurances for a trial period.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.